LabFirst Peptides
Research Peptides
1403 N Tustin Ave, Santa Ana, CA 92705
Ships / Serves Nationally

LabFirst Peptides is a research peptide supplier in Santa Ana, California. Every size is listed with its price and cost per milligram, and volume tiers are fixed: 10% off 10 to 19 vials of one SKU, 15% off 20. Its release specification is public: identity by LC-MS, purity of at least 99% by RP-HPLC, and net content of at least 85% of the label. Lots are tested by Kovera Labs, an independent laboratory, and each published certificate links to Kovera's own verification page with the lot number printed on the vial. The site reports how many of its sizes carry a lot certificate and leaves the rest blank until their lots are tested. If an independent test of a vial does not match its lot certificate, LabFirst refunds that lot in full with no time limit. The catalog covers Retatrutide, Tirzepatide, Semaglutide, BPC-157, TB-500, GHK-Cu, NAD+, Tesamorelin, MOTS-c, SS-31, Semax, Selank and blends. Orders ship from Santa Ana by USPS with tracking, free over $150. Products are for laboratory research use only, not for human or animal use.
Follow & Connect
peptide
Lyophilized research peptide. Lot LF-01B-2609: identity confirmed by LC-MS, purity 99.871% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-05B-2609: identity confirmed by LC-MS, purity 99.612% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-06A-2609: identity confirmed by LC-MS, purity 99.518% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-06B-2609: identity confirmed by LC-MS, purity 99.708% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-11A-2609: identity confirmed by LC-MS, purity 99.682% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-11B-2609: identity confirmed by LC-MS, purity 99.714% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-12A-2609: identity confirmed by LC-MS, purity 99.416% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-15A-2609: identity confirmed by LC-MS, purity 99.748% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-16A-2609: identity confirmed by LC-MS, purity 99.619% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-17A-2609: identity confirmed by LC-MS, purity 99.746% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-18A-2609: identity confirmed by LC-MS, purity 99.786% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-18C-2609: identity confirmed by LC-MS, purity 99.422% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
other
Lyophilized research compound. Lot LF-19B-2609: identity confirmed by LC-MS, purity 99.619% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
other
Lyophilized research compound. Lot LF-19C-2609: identity confirmed by LC-MS, purity 99.766% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-01D-2609: identity confirmed by LC-MS, purity 99.839% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-22B-2609: identity confirmed by LC-MS, purity 99.359% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-29E-2609: identity confirmed by LC-MS, purity 99.761% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-24B-2609: identity confirmed by LC-MS, purity 99.837% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-26A-2609: identity confirmed by LC-MS, purity 99.828% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-26B-2609: identity confirmed by LC-MS, purity 99.736% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-28C-2609: identity confirmed by LC-MS, purity 99.888% by RP-HPLC (Kovera Labs, Sep 29, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-01A-2609: identity confirmed by LC-MS, purity 99.481% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-01F-2609: identity confirmed by LC-MS, purity 99.829% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-04A-2609: identity confirmed by LC-MS, purity 99.447% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-05A-2609: identity confirmed by LC-MS, purity 99.449% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-07A-2609: identity confirmed by LC-MS, purity 99.812% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-07B-2609: identity confirmed by LC-MS, purity 99.706% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-08A-2609: identity confirmed by LC-MS, purity 99.696% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-13A-2609: identity confirmed by LC-MS, purity 99.838% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-14A-2609: identity confirmed by LC-MS, purity 99.752% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-09A-2609: identity confirmed by LC-MS, purity 99.496% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-10A-2609: identity confirmed by LC-MS, purity 99.499% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-20C-2609: identity confirmed by LC-MS, purity 99.648% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-21A-2609: identity confirmed by LC-MS, purity 99.669% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-22A-2609: identity confirmed by LC-MS, purity 99.613% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-23B-2609: identity confirmed by LC-MS, purity 99.656% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-23E-2609: identity confirmed by LC-MS, purity 99.789% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-29B-2609: identity confirmed by LC-MS, purity 99.449% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-29C-2609: identity confirmed by LC-MS, purity 99.784% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-29D-2609: identity confirmed by LC-MS, purity 99.696% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-29F-2609: identity confirmed by LC-MS, purity 99.859% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-29G-2609: identity confirmed by LC-MS, purity 99.526% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-29H-2609: identity confirmed by LC-MS, purity 99.746% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
peptide
Lyophilized research peptide. Lot LF-65B-2609: identity confirmed by LC-MS, purity 99.703% by RP-HPLC, net content, endotoxin, fentanyl and rapid sterility screens all passed (Kovera Labs, Oct 7, 2026). Research use only.
DSIP 5mg (lot LF-09A-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-09A-2609-sterility.pdf
DSIP 5mg (lot LF-09A-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.06 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-09A-2609-endotoxin.pdf
Ipamorelin 5mg (lot LF-13A-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-13A-2609-sterility.pdf
Ipamorelin 5mg (lot LF-13A-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.07 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-13A-2609-endotoxin.pdf
CJC-1295 (No DAC)/Ipamorelin 10mg (lot LF-08A-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-08A-2609-sterility.pdf
CJC-1295 (No DAC)/Ipamorelin 10mg (lot LF-08A-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.05 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-08A-2609-endotoxin.pdf
Retatrutide 40mg (lot LF-01F-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-01F-2609-sterility.pdf
Retatrutide 40mg (lot LF-01F-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.06 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-01F-2609-endotoxin.pdf
Tirzepatide 50mg (lot LF-29G-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-29G-2609-sterility.pdf
Tirzepatide 50mg (lot LF-29G-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.07 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-29G-2609-endotoxin.pdf
Kisspeptin-10 5mg (lot LF-14A-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-14A-2609-sterility.pdf
Kisspeptin-10 5mg (lot LF-14A-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.04 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-14A-2609-endotoxin.pdf
Tirzepatide 40mg (lot LF-29F-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-29F-2609-sterility.pdf
Tirzepatide 40mg (lot LF-29F-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.07 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-29F-2609-endotoxin.pdf
Epithalon 10mg (lot LF-10A-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-10A-2609-sterility.pdf
Epithalon 10mg (lot LF-10A-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.07 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-10A-2609-endotoxin.pdf
Oxytocin 10mg (lot LF-20C-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-20C-2609-sterility.pdf
Oxytocin 10mg (lot LF-20C-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.06 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-20C-2609-endotoxin.pdf
CJC-1295 no DAC 5mg (lot LF-07A-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-07A-2609-sterility.pdf
CJC-1295 no DAC 5mg (lot LF-07A-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.04 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-07A-2609-endotoxin.pdf
Thymosin alpha-1 10mg (lot LF-65B-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-65B-2609-sterility.pdf
Thymosin alpha-1 10mg (lot LF-65B-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.03 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-65B-2609-endotoxin.pdf
BPC-157 5mg (lot LF-05A-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-05A-2609-sterility.pdf
BPC-157 5mg (lot LF-05A-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.07 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-05A-2609-endotoxin.pdf
Tirzepatide 10mg (lot LF-29B-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-29B-2609-sterility.pdf
Tirzepatide 10mg (lot LF-29B-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.08 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-29B-2609-endotoxin.pdf
Tirzepatide 15mg (lot LF-29C-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-29C-2609-sterility.pdf
Tirzepatide 15mg (lot LF-29C-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.04 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-29C-2609-endotoxin.pdf
Semaglutide 30mg (lot LF-23E-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-23E-2609-sterility.pdf
Semaglutide 30mg (lot LF-23E-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.07 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-23E-2609-endotoxin.pdf
PT-141 10mg (lot LF-21A-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-21A-2609-sterility.pdf
PT-141 10mg (lot LF-21A-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.07 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-21A-2609-endotoxin.pdf
Tirzepatide 20mg (lot LF-29D-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-29D-2609-sterility.pdf
Tirzepatide 20mg (lot LF-29D-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.06 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-29D-2609-endotoxin.pdf
Semaglutide 10mg (lot LF-23B-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-23B-2609-sterility.pdf
Semaglutide 10mg (lot LF-23B-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.07 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-23B-2609-endotoxin.pdf
AOD-9604 5mg (lot LF-04A-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-04A-2609-sterility.pdf
AOD-9604 5mg (lot LF-04A-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.05 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-04A-2609-endotoxin.pdf
CJC-1295 no DAC 10mg (lot LF-07B-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-07B-2609-sterility.pdf
CJC-1295 no DAC 10mg (lot LF-07B-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.08 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-07B-2609-endotoxin.pdf
Selank 5mg (lot LF-22A-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-22A-2609-sterility.pdf
Selank 5mg (lot LF-22A-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.07 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-22A-2609-endotoxin.pdf
Retatrutide 5mg (lot LF-01A-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-01A-2609-sterility.pdf
Retatrutide 5mg (lot LF-01A-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.04 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-01A-2609-endotoxin.pdf
Tirzepatide 60mg (lot LF-29H-2609) — Sterility
VerifiedKovera Labs
Rapid sterility screen: no bacterial growth, fungi and yeast not detected. Pass. Report: https://labfirstpeptides.com/coa/LF-29H-2609-sterility.pdf
Tirzepatide 60mg (lot LF-29H-2609) — Endotoxin
VerifiedKovera Labs
Bacterial endotoxin, kinetic LAL per USP <85>: < 0.07 EU/mL against a limit of 0.5 EU/mL. Pass. Report: https://labfirstpeptides.com/coa/LF-29H-2609-endotoxin.pdf
CJC-1295 (No DAC)/Ipamorelin 10mg (lot LF-08A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.696% by RP-HPLC. Net content 11.15 mg (labeled 10 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-08A-2609.pdf
Ipamorelin 5mg (lot LF-13A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.838% by RP-HPLC. Net content 5.83 mg (labeled 5 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-13A-2609.pdf
DSIP 5mg (lot LF-09A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.496% by RP-HPLC. Net content 5.11 mg (labeled 5 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-09A-2609.pdf
Retatrutide 40mg (lot LF-01F-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.829% by RP-HPLC. Net content 41.33 mg (labeled 40 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-01F-2609.pdf
Tirzepatide 50mg (lot LF-29G-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.526% by RP-HPLC. Net content 50.51 mg (labeled 50 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-29G-2609.pdf
Kisspeptin-10 5mg (lot LF-14A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.752% by RP-HPLC. Net content 6.18 mg (labeled 5 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-14A-2609.pdf
Tirzepatide 40mg (lot LF-29F-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.859% by RP-HPLC. Net content 41.83 mg (labeled 40 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-29F-2609.pdf
Epithalon 10mg (lot LF-10A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.499% by RP-HPLC. Net content 10.26 mg (labeled 10 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-10A-2609.pdf
Oxytocin 10mg (lot LF-20C-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.648% by RP-HPLC. Net content 9.67 mg (labeled 10 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-20C-2609.pdf
CJC-1295 no DAC 5mg (lot LF-07A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.812% by RP-HPLC. Net content 5.51 mg (labeled 5 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-07A-2609.pdf
Thymosin alpha-1 10mg (lot LF-65B-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.703% by RP-HPLC. Net content 10.96 mg (labeled 10 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-65B-2609.pdf
BPC-157 5mg (lot LF-05A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.449% by RP-HPLC. Net content 6.24 mg (labeled 5 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-05A-2609.pdf
Tirzepatide 10mg (lot LF-29B-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.449% by RP-HPLC. Net content 10.04 mg (labeled 10 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-29B-2609.pdf
Tirzepatide 15mg (lot LF-29C-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.784% by RP-HPLC. Net content 15.91 mg (labeled 15 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-29C-2609.pdf
Semaglutide 30mg (lot LF-23E-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.789% by RP-HPLC. Net content 30.81 mg (labeled 30 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-23E-2609.pdf
PT-141 10mg (lot LF-21A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.669% by RP-HPLC. Net content 10.04 mg (labeled 10 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-21A-2609.pdf
Tirzepatide 20mg (lot LF-29D-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.696% by RP-HPLC. Net content 22.09 mg (labeled 20 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-29D-2609.pdf
Semaglutide 10mg (lot LF-23B-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.656% by RP-HPLC. Net content 10.24 mg (labeled 10 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-23B-2609.pdf
AOD-9604 5mg (lot LF-04A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.447% by RP-HPLC. Net content 5.57 mg (labeled 5 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-04A-2609.pdf
CJC-1295 no DAC 10mg (lot LF-07B-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.706% by RP-HPLC. Net content 10.76 mg (labeled 10 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-07B-2609.pdf
Selank 5mg (lot LF-22A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.613% by RP-HPLC. Net content 5.83 mg (labeled 5 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-22A-2609.pdf
Retatrutide 5mg (lot LF-01A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.481% by RP-HPLC. Net content 5.12 mg (labeled 5 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-01A-2609.pdf
Tirzepatide 60mg (lot LF-29H-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.746% by RP-HPLC. Net content 62.66 mg (labeled 60 mg). Endotoxin: pass. Sterility screen: no growth. Fentanyl: not detected. Certificate: https://labfirstpeptides.com/coa/LF-29H-2609.pdf
Tirzepatide 30mg (lot LF-29E-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.761% by RP-HPLC. Net content 31.96 mg (labeled 30 mg). Certificate: https://labfirstpeptides.com/coa/LF-29E-2609.pdf
Tesamorelin 20mg (lot LF-28C-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.888% by RP-HPLC. Net content 19.82 mg (labeled 20 mg). Certificate: https://labfirstpeptides.com/coa/LF-28C-2609.pdf
SS-31 50mg (lot LF-26B-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.736% by RP-HPLC. Net content 52.52 mg (labeled 50 mg). Certificate: https://labfirstpeptides.com/coa/LF-26B-2609.pdf
SS-31 10mg (lot LF-26A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.828% by RP-HPLC. Net content 10.52 mg (labeled 10 mg). Certificate: https://labfirstpeptides.com/coa/LF-26A-2609.pdf
Semax 10mg (lot LF-24B-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.837% by RP-HPLC. Net content 9.24 mg (labeled 10 mg). Certificate: https://labfirstpeptides.com/coa/LF-24B-2609.pdf
Selank 10mg (lot LF-22B-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.359% by RP-HPLC. Net content 9.53 mg (labeled 10 mg). Certificate: https://labfirstpeptides.com/coa/LF-22B-2609.pdf
Retatrutide 20mg (lot LF-01D-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.839% by RP-HPLC. Net content 18.88 mg (labeled 20 mg). Certificate: https://labfirstpeptides.com/coa/LF-01D-2609.pdf
NAD+ 1000mg (lot LF-19C-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.766% by RP-HPLC. Net content 1012.13 mg (labeled 1000 mg). Certificate: https://labfirstpeptides.com/coa/LF-19C-2609.pdf
NAD+ 500mg (lot LF-19B-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.619% by RP-HPLC. Net content 519.23 mg (labeled 500 mg). Certificate: https://labfirstpeptides.com/coa/LF-19B-2609.pdf
MOTS-c (Human) 40mg (lot LF-18C-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.422% by RP-HPLC. Net content 38.06 mg (labeled 40 mg). Certificate: https://labfirstpeptides.com/coa/LF-18C-2609.pdf
MOTS-c (Human) 10mg (lot LF-18A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.786% by RP-HPLC. Net content 11.41 mg (labeled 10 mg). Certificate: https://labfirstpeptides.com/coa/LF-18A-2609.pdf
Melanotan II 10mg (lot LF-17A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.746% by RP-HPLC. Net content 10.92 mg (labeled 10 mg). Certificate: https://labfirstpeptides.com/coa/LF-17A-2609.pdf
KPV 10mg (lot LF-16A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.619% by RP-HPLC. Net content 9.42 mg (labeled 10 mg). Certificate: https://labfirstpeptides.com/coa/LF-16A-2609.pdf
KLOW 80mg (lot LF-15A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.748% by RP-HPLC. Net content 88.93 mg (labeled 80 mg). Certificate: https://labfirstpeptides.com/coa/LF-15A-2609.pdf
GLOW 70mg (lot LF-12A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.416% by RP-HPLC. Net content 75.68 mg (labeled 70 mg). Certificate: https://labfirstpeptides.com/coa/LF-12A-2609.pdf
GHK-Cu 100mg (lot LF-11B-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.714% by RP-HPLC. Net content 105.21 mg (labeled 100 mg). Certificate: https://labfirstpeptides.com/coa/LF-11B-2609.pdf
GHK-Cu 50mg (lot LF-11A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.682% by RP-HPLC. Net content 53.21 mg (labeled 50 mg). Certificate: https://labfirstpeptides.com/coa/LF-11A-2609.pdf
BPC 157 + TB-500 Blend 20mg (lot LF-06B-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.708% by RP-HPLC. Net content 21.67 mg (labeled 20 mg). Certificate: https://labfirstpeptides.com/coa/LF-06B-2609.pdf
BPC 157 + TB-500 Blend 10mg (lot LF-06A-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.518% by RP-HPLC. Net content 10.87 mg (labeled 10 mg). Certificate: https://labfirstpeptides.com/coa/LF-06A-2609.pdf
BPC 157 10mg (lot LF-05B-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.612% by RP-HPLC. Net content 14.44 mg (labeled 10 mg). Certificate: https://labfirstpeptides.com/coa/LF-05B-2609.pdf
Retatrutide 10mg (lot LF-01B-2609) — Purity
VerifiedKovera Labs
Identity by LC-MS: conforms. Purity 99.871% by RP-HPLC. Net content 8.83 mg (labeled 10 mg). Certificate: https://labfirstpeptides.com/coa/LF-01B-2609.pdf
5 Questions With Mike Vance
Chief Research Officer · LabFirst Peptides · Santa Ana, California
Q1What's the one peptide you find yourself recommending more than any other right now, and why?
We're a research supplier, so we don't recommend any compound for use. What I recommend more than any peptide is reading the lot certificate before you buy: identity confirmed by LC-MS, purity by RP-HPLC, and the actual net content against the label. Those three numbers tell you more than any brand name.
Q2What's the most common mistake you see people make when they first come to you about peptides?
Trusting a purity percentage on its own. A 99% figure says the material is uniform, not that it's the right molecule or that the vial holds what the label says. A certificate with purity and no identity result or net content has skipped the most important questions.
Q3What's something about the peptide industry the average person would be surprised to learn?
How rarely net content gets tested. Plenty of vials hold noticeably more or less peptide than the label states, and most certificates never measure it. We publish ours for every tested lot, including the ones that came in under label.
Q4If someone reading this is just starting to research peptides, what's the one thing you'd tell them before they buy from anyone?
Match the lot number on the certificate to the vial, then confirm the report with the lab that issued it, not with the seller. If a supplier can't show you a lot-specific certificate you can verify independently, keep looking.
Q5What's a question patients/clients should be asking but usually don't?
"What happens if an independent lab disagrees with your certificate?" A supplier that stands behind its testing should have a written answer. Ours is a full refund on that lot, no time limit.
Customer Reviews
No reviews yet. Be the first to share your experience!
Leave a Review
Send a Message
Get in touch with LabFirst Peptides directly
More Peptide BrandsView all →
Hydro Research
Hydro Research is a science-driven supplier dedicated to elevating the standards of modern research. Built on a passion for innovation and discovery, the company provides high-quality research peptides and chemicals designed to support researchers in achieving reliable, meaningful results. At the core of Hydro Research is a simple yet powerful mission: to empower scientists by delivering exceptional products and dependable service. Every process is guided by a commitment to quality, transparency, and consistency, ensuring researchers have the products they need to pursue breakthrough discoveries with confidence. More than a supplier, Hydro Research positions itself as a true research partner. The team understands the challenges and opportunities that come with scientific exploration and is dedicated to supporting researchers at every stage of their journey—helping turn ambitious ideas into real progress.
Vyal Labs
Vyal Labs is a US manufacturer of research-use-only peptides, registered in Sheridan, Wyoming, with synthesis and testing in US laboratories (the California lab is not disclosed). Manufacturing runs under cGMP and ISO 9001. Every batch is tested by HPLC for purity and by mass spectrometry for identity at Accurate Test Labs, an ISO 17025 accredited laboratory, and the certificate of analysis for each batch is published at vyallabs.com/coa. Orders ship within 48 hours. Products are sold for research use only.
Apex Pharma
We sell retatrutide for research purposes vials and Reta Pen